Protein Expression Trial Service

KAICO provides a recombinant protein expression service based on its proprietary silkworm–baculovirus expression system.

By using silkworm pupae as natural bioreactors, KAICO can produce proteins that are often difficult to express in conventional systems such as E. coli or mammalian cells.

Key Features

• Fully customizable design: Codon optimization, tag swapping, secretory signal adjustment.

• Difficult targets welcome: Expression rate = 100%.

  Complex structures (VLPs), insoluble proteins, membrane, etc..

• Flexible scaling: Scalable production by increasing silkworm pupae. Flexible system for low-volume, multi-protein expression.

**Applications

**KAICO’s service is designed for biopharmaceutical companies, drug developers, and research institutions seeking proteins with high yield, purity, and structural complexity—such as therapeutic proteins, antibodies, and vaccines.